| http://www.w3.org/ns/prov#value | - Refer to the Healthcare Provider Instructions for Use for the On-body Injector for Neulasta for full administration information. 2.4 Advice to Give to Patients Regarding Administration via the On-body Injector for Neulasta Advise patients to avoid activities such as traveling, driving, or operating heavy machinery during hours 26-29 following application of the On-body Injector for Neulasta (this
|
